Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1994-2-18
pubmed:abstractText
The aims of the present study were to characterise an assay for cAMP-binding proteins in ovarian cancer and then to measure levels in a series of tumours with a view to developing a potential prognostic indicator for this disease. Levels and types of binding proteins have been measured in cytosols from 50 ovarian tumours. Binding proteins were detected in all tumours but, as calculated from Scatchard analysis, binding levels ranged from 267 to 12,037 fmol per mg of cytosol protein (mean value of 4248 fmol mg-1). Dissociation constants of binding varied between 0.4 x 10(-8) and 5.9 x 10(-8) (mean value 2.3 x 10(-8)). Types of binding protein were detected by incubation with the photoaffinity ligand 8-N3-[32P]cAMP, followed by polyacrylamide gel electrophoresis and autoradiography. Labelled proteins with molecular weights of 52, 48, 43, 39 and 37 kDa were identified in the cytosols. The proportion and pattern of bands detected varied between different cytosols. The significance of these findings awaits clinical follow-up of the patients.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-166606, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-1689049, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-169888, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-1847645, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-207518, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-210938, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-2155642, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-2224844, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-240451, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-2536620, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-2842878, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-2998423, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-6250347, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-6255017, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-6360384, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-6928231, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-7214351, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-8388698, http://linkedlifedata.com/resource/pubmed/commentcorrection/8286204-942051
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
186-90
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancers.
pubmed:affiliation
Imperial Cancer Research Fund Medical Oncology Unit, Western General Hospital, Edinburgh, UK.
pubmed:publicationType
Journal Article